CogniFit

CogniFit is an interactive and engaging program with an appealing game design. It is mostly suitable for people who can find the time and internal motivation to practice during the week, for the adult to elderly population, and for people who have experienced some sort of cognitive decline (due to injury or illness). The program provides more features on the web platform than on the mobile app. For optimal use, the combination of both devices is recommended. CogniFit developers describe a personalized program based on a short (10-minute) initial assessment and the user’s ongoing performance. In our evaluation, the program’s personalized training most of the time was compatible with areas that needed improvement, but not with areas that needed the most improvement. It could be, that in long term use the program targets the user better toward areas in need of improvement, but at initial use that wasn’t observed. Games are short, easy-to-understand, and attractively designed, which makes training an engaging experience. However, although the recommended goal is 3+ days a week of training, it seems that CogniFit lacks the ability to properly motivate users. The ongoing feedback is based mainly on graphs and progress bars, and there is no integrative verbal feedback in the user’s general recommended goal, strengths, and weaknesses.
As all cognitive training programs, CogniFit is based on the notion that cognitive training in areas of difficulty can slow down cognitive deterioration or improve performance. Although some research has shown a link between the practice of specific cognitive tasks and the improvement or slow of decline in deteriorated functions (like memory, driving, etc.), the current cumulative knowledge in the field of cognitive training does not match the extent of knowledge in other treatment orientations that target other clinical aims (e.g., CBT for depression). In addition, the ability of cognitive training to partly rehabilitate or slow down cognitive impairments related to specific illnesses – such as schizophrenia and Alzheimer’s – is still being evaluated. Therefore, users should be aware of these limitations when utilizing the program.